Cargando…

Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach

BACKGROUND: Similarities in the hijacking mechanisms used by SARS-CoV-2 and several types of cancer, suggest the repurposing of cancer drugs to treat Covid-19. CK2 kinase antagonists have been proposed for cancer treatment. A recent study in cells infected with SARS-CoV-2 found a significant CK2 kin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda, Jamilet, Bringas, Ricardo, Fernandez-de-Cossio, Jorge, Perera-Negrin, Yasser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686809/ https://www.ncbi.nlm.nih.gov/pubmed/34930105 http://dx.doi.org/10.1186/s10020-021-00424-x

Ejemplares similares

A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG
por: Miranda, Jamilet, et al.
Publicado: (2023)

BisoGenet: a new tool for gene network building, visualization and analysis
por: Martin, Alexander, et al.
Publicado: (2010)

A self-consistent probabilistic formulation for inference of interactions
por: Fernandez-de-Cossio, Jorge, et al.
Publicado: (2020)

Predicting CK2 beta-dependent substrates using linear patterns
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015)

Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2
por: Chikhale, Rupesh V., et al.
Publicado: (2021)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells
por: Ramón, Ailyn C., et al.
Publicado: (2022)

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
por: Gottardo, Maria F., et al.
Publicado: (2020)

Tackling SARS-CoV-2: proposed targets and repurposed drugs
por: Joshi, Siddhi, et al.
Publicado: (2020)

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis
por: Quotti Tubi, Laura, et al.
Publicado: (2023)

Using foresight methodologies to tackle SARS-COV-2 related health impacts
por: Tijhuis, M, et al.
Publicado: (2022)

Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection
por: Wu, Yan, et al.
Publicado: (2022)

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
por: Ramón, Ailyn C., et al.
Publicado: (2022)

CK2: channel controller
por: Williams, Ruth
Publicado: (2008)

Mining CK2 in Cancer
por: Ortega, Charina E., et al.
Publicado: (2014)

CK2 and the Hallmarks of Cancer
por: Firnau, May-Britt, et al.
Publicado: (2022)

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945
por: Rosales, Mauro, et al.
Publicado: (2021)

Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation
por: Graciotti, Michele, et al.
Publicado: (2014)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specifc cell-permeable peptide inhibitor
por: Martins, Leila R., et al.
Publicado: (2013)

Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy
por: Sheta, Razan, et al.
Publicado: (2020)

Tackling computing challenges at CERN
por: Girone, Maria, et al.
Publicado: (2023)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support
por: Perera, Yasser, et al.
Publicado: (2020)

CK2 Phosphorylating I(2)(PP2A)/SET Mediates Tau Pathology and Cognitive Impairment
por: Zhang, Qing, et al.
Publicado: (2018)

CK2 as anti-stress factor
por: Watabe, Masahiko, et al.
Publicado: (2012)

Correction: Mining CK2 in Cancer
Publicado: (2015)

CK2 Regulation: Perspectives in 2021
por: Roffey, Scott E., et al.
Publicado: (2021)

CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition
por: Rosales, Mauro, et al.
Publicado: (2022)

Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise
por: Trembley, Janeen H., et al.
Publicado: (2022)

Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2
por: Shah, Syed Muhammad Ali, et al.
Publicado: (2021)

Understanding Molecular Actors of SARS-CoV-2 Virulence to Tackle COVID-19 Outbreak
por: Berisio, Rita
Publicado: (2022)

Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from Rheumatoid arthritis patients
por: Santos Savio, Alicia, et al.
Publicado: (2015)

Tackling computing challenges at CERN (Webcast)
por: Girone, Maria
Publicado: (2021)

Tackling computer challenges at CERN in 2022
por: Girone, Maria
Publicado: (2022)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
por: Li, Chunqiong, et al.
Publicado: (2020)

Impact of confinement during the SARS-CoV-2 pandemic on the incidence of fragility fracture()
por: Naranjo, Antonio, et al.
Publicado: (2021)

Multifaceted CK2 in malignant and healthy T cells
por: Ribeiro, Sérgio T., et al.
Publicado: (2017)

Protein Kinase CK2 in Cancer Energetics
por: Silva-Pavez, Eduardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_am4ihj5ruu52js0p08og8vl7t5